翻訳と辞書 ・ Siloam Springs State Park ・ Siloam Springs, Arkansas ・ Siloam Springs, Missouri ・ Siloam Township, Surry County, North Carolina ・ Siloam tunnel ・ Siloam, Colorado ・ Siloam, Georgia ・ Siloam, Illinois ・ Siloam, New Jersey ・ Siloam, North Carolina ・ Silobela ・ Silobia ・ Silod (Vidhan Sabha constituency) ・ Silodor ・ Silodor Open Pairs ・ Silodosin ・ Siloe, Lesotho ・ Silokhera ・ Silom Line ・ Silon ・ Silonga ・ Silongkoyo, California ・ Silonia ・ Silonia childreni ・ Silonia silondia ・ Silopi ・ Silopi Cudispor ・ Silopi Dam ・ Silopi language ・ Silorba Pachhawari
|
|
Silodosin
Silodosin (trade names Rapaflo (USA), Silodyx (Europe and South Africa), Rapilif (India), Silodal (India), Urief (Japan), Urorec (Russia)) is a medication for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate). ==History== Silodosin received its first marketing approval in Japan in May 2006 under the tradename Urief, which is jointly marketed by Kissei Pharmaceutical Co., Ltd. and Daiichi Sankyo Pharmaceutical Co., Ltd. Kissei licensed the US, Canadian, and Mexican rights for silodosin to Watson Pharmaceuticals, Inc. in 2004. FDA approved silodosin on October 9, 2008.〔(【引用サイトリンク】title=Drugs.com, Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia )〕 Silodosin is marketed under the trade names ''Rapaflo'' in the US and ''Silodyx'' in Europe.〔(European Medicines Agency: Assessment report for Silodyx )〕 and ''Rapilif'' in India (Ipca Urosciences)
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Silodosin」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|